WEX PHARMACEUTICALS INC. (CIK: 0001060012) EDGAR, Information, Filings... CompaniesBIO.Com

WEX PHARMACEUTICALS INC.

Mailing address
1601 - 700 WEST PENDER STREET, VANCOUVER, A1, V6C 1G8
Phone
604-683-8880
State location
A1
State of incorporation
N/A
Fiscal year end
March 31
SIC
2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Filings
N/A

WEX PHARMACEUTICALS INC. (CIK: 0001060012) is an American company incorporated in the state of A1. Head office is located at 1601 - 700 WEST PENDER STREET, VANCOUVER, A1, V6C 1G8. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. WEX PHARMACEUTICALS INC. is a public company and trade via Over-The-Counter (OTC).

Old names:

INTERNATIONAL WEX TECHNOLOGIES INC from 2002-19-Mar to 2002-15-Oct

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by WEX PHARMACEUTICALS INC.

Filings	Format	Description	Filed/Effective	File/Film Number
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0000950123-09-019172 (34 Act) Size: KB	Jun-30-2009	000-29702 09919352
6-K/A	Document	Amendment to Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-018825 (34 Act) Size: KB	Jun-30-2009	000-29702 09917847
20-F	Document	Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0000950123-09-018014 (34 Act) Size: KB	Jun-26-2009	000-29702 09913918
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-017948 (34 Act) Size: KB	Jun-26-2009	000-29702 09913915
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-017889 (34 Act) Size: KB	Jun-26-2009	000-29702 09913908
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-017868 (34 Act) Size: KB	Jun-26-2009	000-29702 09912797
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-015990 (34 Act) Size: KB	Jun-23-2009	000-29702 09904490
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-015784 (34 Act) Size: KB	Jun-22-2009	000-29702 09904489
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-015763 (34 Act) Size: KB	Jun-22-2009	000-29702 09902924
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-015758 (34 Act) Size: KB	Jun-22-2009	000-29702 09902921
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-015755 (34 Act) Size: KB	Jun-22-2009	000-29702 09902918
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-015754 (34 Act) Size: KB	Jun-22-2009	000-29702 09902913
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-012672 (34 Act) Size: KB	Jun-09-2009	000-29702 09883815
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-012671 (34 Act) Size: KB	Jun-09-2009	000-29702 09883813
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-012669 (34 Act) Size: KB	Jun-09-2009	000-29702 09883809
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-012666 (34 Act) Size: KB	Jun-09-2009	000-29702 09883807
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-012663 (34 Act) Size: KB	Jun-09-2009	000-29702 09883806
20-F	Document	Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0000950123-09-012660 (34 Act) Size: KB	Jun-09-2009	000-29702 09883803
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-012659 (34 Act) Size: KB	Jun-09-2009	000-29702 09883800
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950123-09-012657 (34 Act) Size: KB	Jun-09-2009	000-29702 09883797

Recent 20 filings. View all WEX PHARMACEUTICALS INC. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

WEX PHARMACEUTICALS INC. overview
WEX PHARMACEUTICALS INC. job
WEX PHARMACEUTICALS INC. stock
WEX PHARMACEUTICALS INC. ownership
WEX PHARMACEUTICALS INC. CEO
WEX PHARMACEUTICALS INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.